ONCOLOGIC AG

The core activity of ONCOLogic AG is to support diagnostics and pharma in oncology and hematology through specially developed products and services. These include: Consulting in the areas of diagnostics, medication, oncological planning, quality management, and logistics; Development and distribution of products such as the MelaGenix melanoma test and the Swiss Spillkit; Logistics services, including wholesale and pre-wholesale, including GMP packaging; Cyto-safety services, including spill kits and training; Quality and disease management. The company focuses on optimized treatment of cancer patients in Switzerland and offers its partners, such as doctors, institutions, and others, specialized services and products.